Ken Grossmann

Q: What is Ken Grossmann email address?

Email Ken Grossmann at ken.grossmann@providence.org. This email is the most updated Ken Grossmann email found in 2026.

Q: How to contact Ken Grossmann?

To contact Ken Grossmann send an email to ken.grossmann@providence.org. (updated on September 13, 2024)

Division Director - Hematology and Medical Oncology at Providence | Portland, Oregon, United States

About Ken Grossmann

Ken Grossmann is a seasoned physician-scientist with over 25 years of experience in cancer medicine, currently serving as the Division Director of Hematology and Medical Oncology at Providence Cancer Institute. In this pivotal role, he is dedicated to enhancing medical oncology services across a network of hospitals and clinics in the Oregon region, including Portland, Newberg, Willamette Falls, Seaside, and Hood River. His leadership is instrumental in streamlining cancer care delivery, ensuring that patients have access to the latest advancements in treatment and research.

At Providence, Ken is particularly focused on fostering collaboration among an exceptional team of clinicians and researchers. He is actively involved in overseeing key projects that aim to integrate cutting-edge therapies, including those developed through the Center for Cellular Therapeutics. His expertise in molecular biology and clinical trials positions him at the forefront of innovative cancer treatments, allowing him to contribute significantly to the development of personalized medicine approaches that cater to the unique needs of each patient.

Ken's extensive background in both academic and private healthcare systems equips him with a comprehensive understanding of the challenges and opportunities within cancer care. His commitment to advancing clinical research not only enhances patient outcomes but also contributes to the broader field of oncology. As he continues to lead efforts in expanding medical oncology services, Ken Grossmann remains a vital force in shaping the future of cancer treatment in the region, ensuring that Providence Cancer Institute remains a beacon of hope and excellence in patient care.

Ken Grossmann Work